Female pattern hair loss (FPHL) results from a combination of hormones, aging, and genetics, is the most common type alopecia in women. Topical minoxidil remains only US Food Drug Administration (FDA)-approved treatment for this condition, although numerous other therapies have demonstrated efficacy recent years. Spironolactone, weak androgen receptor inhibitor, largely effective at various dos...

BACKGROUND Hair loss is an unwelcome event at any age, but it can be particularly distressing for adolescents and their families. While androgenetic alopecia (AGA) is the most common form of hair loss in adults, little is known about its prevalence, clinical features and response to treatments in the paediatric population. OBJECTIVES To better characterize the causes of alopecia in a paediatr...

BACKGROUND Androgens are thought to have an adverse effect on female scalp hair growth. However, our clinical experience of androgen replacement therapy in women with androgen deficiency, in which hair loss was seldom reported, led us to question this concept. OBJECTIVES To evaluate the effect of subcutaneous testosterone therapy on scalp hair growth in female patients. METHODS A total of 2...

Patterned hair loss also known as androgenetic alopecia (AGA), is a hereditary androgen dependent disorder characterised by a progressive process that causes a gradual conversion of terminal hair into miniaturized hair defined by various patterns [1]. It is a feature of men who have sufficient circulating androgens. Male pattern hair loss is characterised by its typical bitemporal recession of ...

Topical minoxidil, the only approved treatment for female pattern hair loss (FPHL), has been associated with scalp allergic contact dermatitis (ACD). We report the case of 2 female patients who developed ACD from minoxidil solution with severe telogen effluvium and psoriasiform scalp dermatitis. Scalp dermoscopy was useful to identify the psoriasiform vascular pattern, whereas patch testing mad...

BACKGROUND: Hair loss is a common complaint among women and may be associated with psychological disturbances. OBJECTIVES: This study investigated dermatology patients with respect to the prevalence of complaints of hair loss and the association between these complaints and symptoms of depression. METHODS: A cross-sectional study was conducted with female outpatients over 20 years of age with n...

Telogen effluvium (TE) is the most common cause of diffuse hair loss in adult females. TE, along with female pattern hair loss (FPHL) and chronic telogen effluvium (CTE), accounts for the majority of diffuse alopecia cases. Abrupt, rapid, generalized shedding of normal club hairs, 2-3 months after a triggering event like parturition, high fever, major surgery, etc. indicates TE, while gradual d...